These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29652797)

  • 1. The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease.
    Koppe L; Fouque D; Soulage CO
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29652797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study.
    Wiese GN; Biruete A; Stremke ER; Lindemann SR; Jannasch A; Moorthi RN; Moe SM; Swanson KS; Cross TW; Hill Gallant KM
    J Ren Nutr; 2024 Jan; 34(1):26-34. PubMed ID: 37468049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.
    Ondrussek-Sekac M; Navas-Carrillo D; Orenes-Piñero E
    Crit Rev Food Sci Nutr; 2021; 61(9):1490-1502. PubMed ID: 32393049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Cardiovascular Uremic Toxicities.
    Velasquez MT; Centron P; Barrows I; Dwivedi R; Raj DS
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29997362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.
    Vitetta L; Gobe G
    Mol Nutr Food Res; 2013 May; 57(5):824-32. PubMed ID: 23450842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Microbiome and Uremic Solutes.
    Zaidan N; Nazzal L
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Renal Clinician's Guide to the Gut Microbiota.
    Snelson M; Biruete A; McFarlane C; Campbell K
    J Ren Nutr; 2020 Sep; 30(5):384-395. PubMed ID: 31928802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model.
    Mishima E; Fukuda S; Kanemitsu Y; Saigusa D; Mukawa C; Asaji K; Matsumoto Y; Tsukamoto H; Tachikawa T; Tsukimi T; Fukuda NN; Ho HJ; Kikuchi K; Suzuki C; Nanto F; Suzuki T; Ito S; Soga T; Tomioka Y; Abe T
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F824-F833. PubMed ID: 29167170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
    Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
    Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.
    Koppe L; Fouque D; Soulage CO
    Curr Diab Rep; 2018 Sep; 18(10):97. PubMed ID: 30194541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota as a Source of Uremic Toxins.
    Popkov VA; Zharikova AA; Demchenko EA; Andrianova NV; Zorov DB; Plotnikov EY
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease.
    Koppe L; Soulage CO
    Kidney Int; 2022 Oct; 102(4):728-739. PubMed ID: 35870642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.